|
WO2007116432A1
(ja)
|
2006-03-30 |
2007-10-18 |
Aichi Prefecture |
キャノロールまたはそのプロドラッグ（ｐｄ）を含む抗炎症剤および癌予防剤ならびにこれらを含む医薬、化粧品および食品
|
|
EP2058309A4
(en)
*
|
2006-08-04 |
2010-12-22 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
|
BRPI0716239A2
(pt)
|
2006-08-30 |
2013-08-13 |
Cellzome Ltd |
derivados de triazol como inibidores de cinase
|
|
CA2672494A1
(en)
|
2006-12-14 |
2008-06-19 |
Nps Pharmaceuticals, Inc. |
Use of d-serine derivatives for the treatment of anxiety disorders
|
|
US8263585B2
(en)
|
2007-05-04 |
2012-09-11 |
Novartis Ag |
Organic compounds
|
|
TW200911798A
(en)
*
|
2007-08-02 |
2009-03-16 |
Amgen Inc |
PI3 kinase modulators and methods of use
|
|
WO2009021990A1
(en)
*
|
2007-08-14 |
2009-02-19 |
Bayer Schering Pharma Aktiengesellschaft |
Fused imidazoles for cancer treatment
|
|
EP2062893A1
(en)
*
|
2007-10-18 |
2009-05-27 |
Bayer Schering Pharma AG |
Fused imidazoles for cancer treatment
|
|
ES2400604T3
(es)
*
|
2007-08-17 |
2013-04-11 |
Icagen, Inc. |
Heterociclos como moduladores del canal de potasio
|
|
US8431608B2
(en)
|
2007-08-17 |
2013-04-30 |
Icagen Inc. |
Heterocycles as potassium channel modulators
|
|
CA2691448A1
(en)
|
2007-08-31 |
2009-03-05 |
Dominique Swinnen |
Triazolopyridine compounds and their use as ask inhibitors
|
|
AU2008328882A1
(en)
*
|
2007-11-27 |
2009-06-04 |
Cellzome Limited |
Amino triazoles as PI3K inhibitors
|
|
AU2008343813B2
(en)
*
|
2007-12-19 |
2012-04-12 |
Amgen Inc. |
Inhibitors of PI3 kinase
|
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
WO2009126635A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Abbott Laboratories |
2-amino-benzothiazole derivates useful as inhibitors of rock kinases
|
|
MX2010011370A
(es)
|
2008-04-16 |
2010-12-15 |
Vertex Pharma |
Inhibidores de fosfatidilinositol 3-cinasa.
|
|
EP2277881A4
(en)
|
2008-04-18 |
2011-09-07 |
Shionogi & Co |
HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON P13K
|
|
AR071523A1
(es)
*
|
2008-04-30 |
2010-06-23 |
Merck Serono Sa |
Compuestos biciclicos fusionados, un proceso para su preparacion, el compuesto para ser utilizado como medicamento en el tratamiento y profilaxis de enfermedades, una composicion farmaceutica y un conjunto que comprende paquetes separados del compuesto y de un ingrediente activo del medicamento
|
|
WO2009155052A1
(en)
*
|
2008-05-28 |
2009-12-23 |
Wyeth |
3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
|
|
CA2725014C
(en)
|
2008-05-30 |
2014-06-17 |
Amgen Inc. |
Inhibitors of pi3 kinase
|
|
CN102131389A
(zh)
|
2008-06-20 |
2011-07-20 |
健泰科生物技术公司 |
三唑并吡啶jak抑制剂化合物和方法
|
|
WO2009155565A1
(en)
|
2008-06-20 |
2009-12-23 |
Genentech, Inc. |
Triazolopyridine jak inhibitor compounds and methods
|
|
WO2010008847A2
(en)
*
|
2008-06-24 |
2010-01-21 |
Takeda Pharmaceutical Company Limited |
Pi3k/m tor inhibitors
|
|
WO2010007100A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Ltd |
7-substituted amino triazoles as pi3k inhibitors
|
|
WO2010007099A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
|
WO2010057877A1
(en)
*
|
2008-11-18 |
2010-05-27 |
Cellzome Limited |
7-pyridinyl- or phenyl- substituted triazolo [1, 5 -a] pyridines as pi3k inhibitors
|
|
ES2921576T3
(es)
|
2008-12-19 |
2022-08-29 |
Vertex Pharma |
Compuestos útiles como inhibidores de la quinasa ATR
|
|
WO2010092015A1
(en)
|
2009-02-10 |
2010-08-19 |
Cellzome Limited |
Urea triazololo [1, 5-a] pyridine derivatives as pi3k inhibitors
|
|
SG173610A1
(en)
|
2009-02-13 |
2011-09-29 |
Fovea Pharmaceuticals Sa |
[1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
|
|
MX2011008645A
(es)
|
2009-02-17 |
2011-09-30 |
Vertex Pharma |
Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa.
|
|
WO2010135014A1
(en)
*
|
2009-02-27 |
2010-11-25 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
WO2010100144A1
(en)
*
|
2009-03-04 |
2010-09-10 |
Merck Serono S.A. |
Fused bicyclic compounds as inhibitors for pi3 kinase
|
|
JP2012521354A
(ja)
|
2009-03-20 |
2012-09-13 |
アムジエン・インコーポレーテツド |
Ｐｉ３キナーゼの阻害薬
|
|
US20120071475A1
(en)
|
2009-04-27 |
2012-03-22 |
Shionogi & Co., Ltd. |
Urea derivatives having pi3k-inhibiting activity
|
|
WO2010133534A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Cellzome Limited |
Bicyclic amino substituted compounds as pi3k inhibitors
|
|
EP2432782A1
(en)
*
|
2009-05-20 |
2012-03-28 |
Cellzome Ag |
Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
|
|
EP2438066A2
(en)
|
2009-06-05 |
2012-04-11 |
Cephalon, Inc. |
PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVES
|
|
KR101763656B1
(ko)
|
2009-06-29 |
2017-08-01 |
인사이트 홀딩스 코포레이션 |
Ｐｉ3ｋ 저해물질로서의 피리미디논
|
|
AU2010268058A1
(en)
|
2009-07-02 |
2012-01-19 |
Novartis Ag |
2-carboxamide cycloamino ureas useful as PI3K inhibitors
|
|
US8293753B2
(en)
*
|
2009-07-02 |
2012-10-23 |
Novartis Ag |
Substituted 2-carboxamide cycloamino ureas
|
|
NZ598220A
(en)
*
|
2009-08-17 |
2014-02-28 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
US8487102B2
(en)
*
|
2010-04-20 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Pyrrazolopyridine compounds as dual NK1/NK3 receptor antagonists
|
|
EP2563792B1
(en)
|
2010-04-28 |
2014-08-27 |
Bristol-Myers Squibb Company |
Imidazopyridazinyl compounds and their uses for cancer
|
|
US9062008B2
(en)
*
|
2010-05-12 |
2015-06-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
US9334244B2
(en)
|
2010-05-12 |
2016-05-10 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
CA2798760A1
(en)
*
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
2-aminopyridine derivatives useful as inhibitors of atr kinase
|
|
NZ603477A
(en)
|
2010-05-12 |
2014-09-26 |
Vertex Pharma |
Compounds useful as inhibitors of atr kinase
|
|
CN103153062B
(zh)
*
|
2010-05-24 |
2015-07-15 |
因特利凯有限责任公司 |
杂环化合物及其用途
|
|
AR081960A1
(es)
|
2010-06-22 |
2012-10-31 |
Fovea Pharmaceuticals Sa |
Compuestos heterociclicos, su preparacion y su aplicacion terapeutica
|
|
EP3660016A1
(en)
|
2010-12-20 |
2020-06-03 |
Incyte Holdings Corporation |
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
|
|
BR112013018286A2
(pt)
*
|
2011-01-19 |
2016-11-16 |
Galapagos Nv |
derivados d azetidina úteis para o tratamento de doenças metabólicas e inflamatórias
|
|
US9295673B2
(en)
|
2011-02-23 |
2016-03-29 |
Intellikine Llc |
Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
|
HUE026323T2
(en)
|
2011-04-07 |
2016-05-30 |
Bayer Ip Gmbh |
Imidazopyridazines as akt kinase inhibitors
|
|
PT3513793T
(pt)
|
2011-09-02 |
2021-05-10 |
Incyte Holdings Corp |
Heterociclilaminas como inibidores de pi3k
|
|
CN108685922A
(zh)
|
2011-09-30 |
2018-10-23 |
沃泰克斯药物股份有限公司 |
用atr抑制剂治疗胰腺癌和非小细胞肺癌
|
|
CN106496173A
(zh)
|
2011-09-30 |
2017-03-15 |
沃泰克斯药物股份有限公司 |
用于制备可用作atr激酶抑制剂的化合物的方法
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
CN108478577A
(zh)
|
2012-04-05 |
2018-09-04 |
沃泰克斯药物股份有限公司 |
可用作atr激酶抑制剂的化合物及其组合疗法
|
|
KR20160027219A
(ko)
|
2012-05-23 |
2016-03-09 |
에프. 호프만-라 로슈 아게 |
내배엽 및 간세포를 수득하고 사용하는 조성물 및 방법
|
|
CN104619709B
(zh)
*
|
2012-07-13 |
2016-11-09 |
Ucb生物制药私人有限公司 |
作为tnf活性调节剂的咪唑并吡啶衍生物
|
|
DK2904406T3
(en)
|
2012-10-04 |
2018-06-18 |
Vertex Pharma |
METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
|
|
CA2905123A1
(en)
|
2013-03-15 |
2014-09-18 |
Genentech, Inc. |
Methods of treating cancer and preventing cancer drug resistance
|
|
US9227978B2
(en)
|
2013-03-15 |
2016-01-05 |
Araxes Pharma Llc |
Covalent inhibitors of Kras G12C
|
|
WO2014146994A1
(en)
*
|
2013-03-20 |
2014-09-25 |
F. Hoffmann-La Roche Ag |
Urea derivatives and their use as fatty-acid binding protein (fabp) inhibitors
|
|
JO3805B1
(ar)
|
2013-10-10 |
2021-01-31 |
Araxes Pharma Llc |
مثبطات كراس جي12سي
|
|
US10233176B2
(en)
*
|
2013-11-27 |
2019-03-19 |
Signalchem Lifesciences Corporation |
Aminopyridine derivatives as TAM family kinase inhibitors
|
|
GB201321733D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
EP3105219B9
(en)
|
2014-02-13 |
2018-10-03 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
JP6602779B2
(ja)
|
2014-02-13 |
2019-11-06 |
インサイト・コーポレイション |
Ｌｓｄ１阻害剤としてのシクロプロピルアミン類
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
EP3105218B1
(en)
|
2014-02-13 |
2019-09-25 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
US9598424B2
(en)
|
2014-03-06 |
2017-03-21 |
Takeda Pharmaceutical Company Limited |
Heteroarylamide inhibitors of TBK1
|
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
|
US9695167B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
JO3556B1
(ar)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
علاجات مدمجة لمعالجة السرطان
|
|
AU2015366202B2
(en)
*
|
2014-12-19 |
2020-01-02 |
Janssen Pharmaceutica Nv |
Heterocyclyl linked imidazopyridazine derivatives as PI3Kbeta inhibitors
|
|
SG10201907576SA
(en)
|
2015-02-27 |
2019-09-27 |
Incyte Corp |
Salts of pi3k inhibitor and processes for their preparation
|
|
EP3277689B1
(en)
|
2015-04-03 |
2019-09-04 |
Incyte Corporation |
Heterocyclic compounds as lsd1 inhibitors
|
|
ES2898765T3
(es)
|
2015-04-10 |
2022-03-08 |
Araxes Pharma Llc |
Compuestos de quinazolina sustituidos y métodos de uso de los mismos
|
|
US10428064B2
(en)
|
2015-04-15 |
2019-10-01 |
Araxes Pharma Llc |
Fused-tricyclic inhibitors of KRAS and methods of use thereof
|
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
|
US10144724B2
(en)
|
2015-07-22 |
2018-12-04 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
|
MY189367A
(en)
|
2015-08-12 |
2022-02-08 |
Incyte Corp |
Salts of an lsd1 inhibitor
|
|
WO2017058728A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3356347A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
EP3356359B1
(en)
|
2015-09-28 |
2021-10-20 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
EP3356351A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058805A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3356349A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058902A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
KR20180081596A
(ko)
|
2015-11-16 |
2018-07-16 |
아락세스 파마 엘엘씨 |
치환된 헤테로사이클릭 그룹을 포함하는 2-치환된 퀴나졸린 화합물 및 이의 사용 방법
|
|
WO2017152126A1
(en)
|
2016-03-03 |
2017-09-08 |
Cornell University |
Small molecule ire1-alpha inhibitors
|
|
TWI833686B
(zh)
|
2016-04-22 |
2024-03-01 |
美商英塞特公司 |
Lsd1 抑制劑之調配物
|
|
US11352328B2
(en)
|
2016-07-12 |
2022-06-07 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus
|
|
US10646488B2
(en)
|
2016-07-13 |
2020-05-12 |
Araxes Pharma Llc |
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
|
|
WO2018064510A1
(en)
|
2016-09-29 |
2018-04-05 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3523289A1
(en)
|
2016-10-07 |
2019-08-14 |
Araxes Pharma LLC |
Heterocyclic compounds as inhibitors of ras and methods of use thereof
|
|
US11136308B2
(en)
|
2017-01-26 |
2021-10-05 |
Araxes Pharma Llc |
Substituted quinazoline and quinazolinone compounds and methods of use thereof
|
|
WO2018140513A1
(en)
*
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
|
EP3573954A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
|
JP7327802B2
(ja)
|
2017-01-26 |
2023-08-16 |
アラクセス ファーマ エルエルシー |
縮合ヘテロ－ヘテロ二環式化合物およびその使用方法
|
|
WO2018140599A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
Benzothiophene and benzothiazole compounds and methods of use thereof
|
|
WO2018218069A1
(en)
|
2017-05-25 |
2018-11-29 |
Araxes Pharma Llc |
Quinazoline derivatives as modulators of mutant kras, hras or nras
|
|
US10745385B2
(en)
|
2017-05-25 |
2020-08-18 |
Araxes Pharma Llc |
Covalent inhibitors of KRAS
|
|
CN110869357A
(zh)
|
2017-05-25 |
2020-03-06 |
亚瑞克西斯制药公司 |
化合物及其用于治疗癌症的使用方法
|
|
AU2018346051B2
(en)
|
2017-10-02 |
2022-11-10 |
1st Biotherapeutics Inc. |
Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
|
|
DK3704118T3
(da)
*
|
2017-10-30 |
2022-03-14 |
Bristol Myers Squibb Co |
Aminoimidazopyrazin som kinasehæmmere
|
|
WO2019126731A1
(en)
*
|
2017-12-22 |
2019-06-27 |
Petra Pharma Corporation |
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
|
US11919902B2
(en)
|
2017-12-22 |
2024-03-05 |
Hibercell, Inc. |
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
|
CA3086668A1
(en)
*
|
2018-02-05 |
2019-08-08 |
Universite De Strasbourg |
Compounds and compositions for the treatment of pain
|
|
SG11202011680YA
(en)
|
2018-06-01 |
2020-12-30 |
Incyte Corp |
Dosing regimen for the treatment of pi3k related disorders
|
|
CA3102279A1
(en)
|
2018-06-01 |
2019-12-05 |
Cornell University |
Combination therapy for pi3k-associated disease or disorder
|
|
MX2021000887A
(es)
|
2018-08-01 |
2021-03-31 |
Araxes Pharma Llc |
Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer.
|
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
|
US12419865B2
(en)
|
2018-12-06 |
2025-09-23 |
Arisan Therapeutics Inc. |
Compounds for the treatment of arenavirus infection
|
|
AU2020224401A1
(en)
|
2019-02-22 |
2021-10-14 |
1ST Biotherapeutics, Inc. |
Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders
|
|
EP3934702B1
(en)
*
|
2019-03-07 |
2024-05-08 |
1st Biotherapeutics, Inc. |
[ 18f]-labeled benzothiazole derivative as pet radiotracer
|
|
US10385046B1
(en)
|
2019-03-19 |
2019-08-20 |
1ST Biotherapeutics, Inc. |
Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders
|
|
KR20210134065A
(ko)
*
|
2019-03-28 |
2021-11-08 |
주식회사 퍼스트바이오테라퓨틱스 |
벤조티아졸 화합물의 약제학적 염, 다형체 및 이들의 제조 방법
|
|
WO2020201773A1
(en)
*
|
2019-04-05 |
2020-10-08 |
Storm Therapeutics Ltd |
Mettl3 inhibitory compounds
|
|
TW202112767A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
|
|
US12441707B2
(en)
|
2019-12-30 |
2025-10-14 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
CN112047950B
(zh)
*
|
2020-09-14 |
2023-07-25 |
华东师范大学 |
咪唑并吡嗪类衍生物及其合成方法和应用
|
|
KR20230067669A
(ko)
*
|
2020-09-15 |
2023-05-16 |
주식회사 퍼스트바이오테라퓨틱스 |
2-아미노-3-카르보닐 이미다조피리딘 및 피라졸로피리딘 화합물
|
|
WO2022064459A1
(en)
*
|
2020-09-28 |
2022-03-31 |
1ST Biotherapeutics, Inc. |
Indazoles as hematopoietic progenitor kinase 1 (hpk1) inhibitors and methods of using same
|
|
CN116456818B
(zh)
|
2020-09-30 |
2025-12-05 |
住友化学株式会社 |
杂环化合物和含有该杂环化合物的有害节肢动物防除组合物
|
|
WO2023134692A1
(zh)
*
|
2022-01-13 |
2023-07-20 |
浙江同源康医药股份有限公司 |
多环类化合物及其用途
|
|
CN115850263B
(zh)
*
|
2022-12-28 |
2025-06-17 |
浙江工业大学 |
一种2,7-二取代苯并噻唑类化合物及其应用
|
|
CN119841829A
(zh)
*
|
2023-10-18 |
2025-04-18 |
中国科学院合肥物质科学研究院 |
用于治疗PI3Kγ介导的疾病的化合物及其用途
|